CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Appropriations History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Appropriations | ₹22,179 Cr | ₹18,471 Cr | ₹16,054 Cr | ₹13,523 Cr | ₹11,798 Cr |
What is the latest Appropriations of CIPLA ?
Year | Appropriations |
---|---|
Mar2024 | ₹22,179 Cr |
Mar2023 | ₹18,471 Cr |
Mar2022 | ₹16,054 Cr |
Mar2021 | ₹13,523 Cr |
Mar2020 | ₹11,798 Cr |
How is Appropriations of CIPLA Trending?
Years | Appropriations | % Change | |
---|---|---|---|
Mar2024 | ₹22,179 Cr | 20.07 | |
Mar2023 | ₹18,471 Cr | 15.06 | |
Mar2022 | ₹16,054 Cr | 18.72 | |
Mar2021 | ₹13,523 Cr | 14.62 | |
Mar2020 | ₹11,798 Cr | - |
Compare Appropriations of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹125,533.3 Cr | 1.7% | 2% | 13.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 5.4% | 3.2% | 20.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 1.9% | 2% | 59.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | 2.8% | 2.3% | 22.8% | Stock Analytics | |
MANKIND PHARMA | ₹105,587.0 Cr | -0.6% | 7.9% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | 2.1% | -0.9% | -1.5% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.7% |
2% |
13.2% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses